Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.42 |
| ▸ | CNR1 | P21554 | 3/20 | 0.38 |
| ▸ | SCARB1 | Q8WTV0 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23801795 | 0.94 | CNR2 (0.37) | CNR2CNR1KDM4ELMNAMAPT | |
| SCHEMBL23802425 | 0.94 | CNR2 (0.38) | CNR2CNR1SCARB1KDM4ELMNA | |
| SCHEMBL23802416 | 0.91 | CNR2 (0.40) | CNR2CNR1SCARB1 | |
| SCHEMBL23801359 | 0.86 | CNR2 (0.35) | CNR2CNR1KDM4EHPGDHTT | |
| SCHEMBL25515703 | 0.83 | CNR2 (0.45) | CNR2CNR1SCARB1LMNA | |
| SCHEMBL25515641 | 0.82 | CNR2 (0.41) | CNR2CNR1KDM4ELMNAMAPT | |
| SCHEMBL25515630 | 0.81 | CNR2 (0.41) | CNR2CNR1KDM4ELMNAMAPT | |
| SCHEMBL23802099 | 0.81 | CNR2 (0.39) | CNR2CNR1SCARB1LMNAMAPT | |
| SCHEMBL23802133 | 0.81 | CNR2 (0.45) | CNR2CNR1SCARB1KDM4ELMNA | |
| SCHEMBL25515619 | 0.78 | CNR2 (0.42) | CNR2CNR1KDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | CNR2 663/4885CNR1 878/4885SCARB1 2372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.